Chandan Healthcare Ltd Faces Technical Momentum Shift Amid Mixed Market Returns

Technical Trend Overview and Price Movement

As of 13 Jul 2026, Chandan Healthcare Ltd’s share price closed at ₹249.65, down 1.75% from the previous close of ₹254.10. The intraday range saw a high of ₹263.35 and a low of ₹247.05, indicating some volatility within the session. The stock remains well below its 52-week high of ₹358.00 but comfortably above its 52-week low of ₹185.40, suggesting a broad trading range over the past year.

The technical trend has shifted from mildly bullish to sideways, signalling a pause in upward momentum. This transition is critical for traders and investors as it suggests that the stock may be consolidating before its next directional move. The daily moving averages have turned mildly bearish, indicating short-term selling pressure, while weekly and monthly indicators present a more mixed outlook.

MACD and Momentum Indicators

The Moving Average Convergence Divergence (MACD) indicator remains mildly bullish on the weekly timeframe, reflecting some underlying positive momentum. However, the monthly MACD does not currently provide a clear signal, underscoring the lack of strong directional conviction over the longer term. This divergence between weekly and monthly MACD readings suggests that while short-term momentum may be intact, longer-term trends are less certain.

The Know Sure Thing (KST) indicator on the weekly chart also supports a mildly bullish stance, reinforcing the notion of moderate upward momentum in the near term. Conversely, the daily moving averages’ mildly bearish signal tempers this optimism, highlighting the importance of monitoring short-term price action closely.

RSI and Bollinger Bands Analysis

The Relative Strength Index (RSI) on both weekly and monthly timeframes currently shows no definitive signal, hovering in neutral territory. This lack of RSI extremes suggests that the stock is neither overbought nor oversold, consistent with the sideways trend observed in price action.

Bollinger Bands on the weekly chart remain mildly bullish, indicating that price volatility is contained within an upward bias. The bands have not expanded significantly, which aligns with the sideways momentum and suggests limited price breakouts in the immediate term.

Volume and Dow Theory Signals

On-Balance Volume (OBV) analysis reveals a mildly bullish trend on the weekly scale, implying that buying volume is slightly outweighing selling pressure. However, the monthly OBV shows no clear trend, reinforcing the mixed signals from other monthly indicators.

Dow Theory assessments on both weekly and monthly charts remain mildly bullish, signalling that the broader market sentiment for Chandan Healthcare Ltd is cautiously optimistic despite recent price softness.

Comparative Returns and Market Context

Chandan Healthcare Ltd’s recent returns present a mixed picture when compared with the broader Sensex index. Over the past week, the stock declined by 1.32%, underperforming the Sensex’s modest 0.26% loss. However, over the last month, the stock outperformed significantly with a 9.18% gain versus the Sensex’s 4.27% rise.

Year-to-date (YTD), the stock has declined sharply by 23.08%, considerably worse than the Sensex’s 7.36% fall. Yet, over the trailing one-year period, Chandan Healthcare Ltd has delivered a robust 20.02% return, outperforming the Sensex’s negative 4.53% return. This volatility highlights the stock’s sensitivity to sector-specific and company-level developments.

Longer-term returns for the Sensex show strong growth, with 25.06% over three years, 54.28% over five years, and an impressive 190.84% over ten years. Chandan Healthcare Ltd’s absence of comparable long-term data underscores its micro-cap status and relatively recent market presence.

Mojo Score and Grade Revision

MarketsMOJO’s latest assessment downgraded Chandan Healthcare Ltd’s Mojo Grade from Hold to Sell on 7 Jul 2026, reflecting a deterioration in technical and fundamental outlook. The current Mojo Score stands at 45.0, signalling weak momentum and caution for investors. The micro-cap classification further emphasises the stock’s higher risk profile relative to larger hospital sector peers.

Investors should weigh this downgrade alongside the mixed technical signals, particularly the divergence between short-term bearish moving averages and mildly bullish weekly momentum indicators.

Implications for Investors and Traders

The shift to a sideways trend suggests that Chandan Healthcare Ltd is currently in a consolidation phase, with neither buyers nor sellers exerting decisive control. Traders may find opportunities in short-term swings, but the mildly bearish daily moving averages caution against aggressive long positions without confirmation of a trend reversal.

Long-term investors should monitor the monthly MACD and OBV for clearer directional cues, as well as any fundamental developments that could influence the hospital sector’s outlook. Given the stock’s micro-cap status and recent downgrade, a conservative approach with close risk management is advisable.

Summary and Outlook

Chandan Healthcare Ltd’s technical parameters reveal a stock at a crossroads. The transition from mildly bullish to sideways momentum, combined with a downgrade to a Sell rating, signals caution. While weekly momentum indicators such as MACD and KST remain mildly positive, daily moving averages and neutral RSI readings suggest limited near-term upside.

Investors should closely monitor price action around the ₹247 to ₹263 range, which has recently defined intraday volatility. A sustained break above the upper Bollinger Band or a monthly MACD bullish crossover could signal renewed strength. Conversely, a drop below the 52-week low of ₹185.40 would confirm a bearish trend.

Given the hospital sector’s evolving dynamics and Chandan Healthcare Ltd’s micro-cap status, a balanced approach combining technical analysis with fundamental review is essential for informed decision-making.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today